Visium Asset Management’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-118,841
Closed -$9.27M 304
2016
Q2
$9.27M Sell
118,841
-229,392
-66% -$16.4M 0.65% 30
2016
Q1
$19.2M Buy
+348,233
New +$19M 0.33% 74
2015
Q4
Sell
-6,444
Closed -$407K 984
2015
Q3
$407K Buy
+6,444
New +$460K 0.01% 615
2015
Q2
Sell
-8,599
Closed -$562K 1377
2015
Q1
$562K Sell
8,599
-4,081
-32% -$271K 0.01% 659
2014
Q4
$825K Buy
12,680
+2,406
+23% +$155K 0.01% 580
2014
Q3
$618K Buy
+10,274
New +$671K 0.01% 700
2014
Q2
Sell
-140,407
Closed -$9.18M 1260
2014
Q1
$9.18M Buy
140,407
+18,073
+15% +$1.18M 0.15% 128
2013
Q4
$7.58M Sell
122,334
-36,135
-23% -$2.09M 0.15% 131
2013
Q3
$8.5M Buy
158,469
+138,850
+708% +$7.15M 0.19% 88
2013
Q2
$896K Buy
+19,619
New +$850K 0.02% 363

Other funds holding STJ

Visium Asset Management's STJ Position: Q3 2016 in Review

Visium Asset Management sold out of St Jude Medical (STJ) in Q3 2016, closing a stake of 118,841 shares — an estimated $9.27M sold.

Visium Asset Management first reported a position in STJ in Q2 2013 and held it in 10 quarters. The position peaked at $19.2M in Q1 2016. 571 funds tracked by Wall St. Rank hold STJ as of Q3 2016.

  • Visium Asset Management reported no remaining St Jude Medical position as of Q3 2016 after selling out during the quarter.
  • Visium Asset Management sold 118,841 St Jude Medical shares in Q3 2016, an estimated $9.27M.
  • Visium Asset Management first reported a position in St Jude Medical in Q2 2013 and held it in 10 quarters.
  • Visium Asset Management's St Jude Medical position peaked at $19.2M in Q1 2016.
  • 571 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2016.

Based on Visium Asset Management's 13F filing for Q3 2016.